Analysts Set Blend Labs, Inc. (NYSE:BLND) Price Target at $4.88

Key Points

• Blend Labs, Inc. has received an average recommendation of "Moderate Buy" from analysts, with target prices varying from $3.50 to $5.25.
• Insider trading activity has been significant, with key executives selling over 561,736 shares in the last ninety days, indicating a decrease in their ownership positions.
• Despite a recent 16.6% stock price increase, Blend Labs reported a loss of $0.03 EPS for the previous quarter, falling short of analysts' expectations.

Shares of Blend Labs, Inc. (NYSE:BLND - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the seven analysts that are covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $4.8833.

BLND has been the topic of a number of recent analyst reports. UBS Group dropped their price objective on Blend Labs from $4.00 to $3.50 and set a "neutral" rating on the stock in a research note on Friday, August 8th. Canaccord Genuity Group reiterated a "buy" rating and issued a $5.25 price objective on shares of Blend Labs in a research note on Friday, August 22nd. Keefe, Bruyette & Woods dropped their price objective on Blend Labs from $4.00 to $3.75 and set a "market perform" rating on the stock in a research note on Friday, August 8th. Wall Street Zen upgraded Blend Labs from a "sell" rating to a "hold" rating in a research note on Sunday, August 17th. Finally, The Goldman Sachs Group dropped their price objective on Blend Labs from $5.60 to $4.80 and set a "buy" rating on the stock in a research note on Monday, May 12th.

Insider Transactions at Blend Labs

In related news, insider Nima Ghamsari sold 311,886 shares of the business's stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $2.90, for a total transaction of $904,469.40. Following the transaction, the insider directly owned 5,754,051 shares in the company, valued at $16,686,747.90. The trade was a 5.14% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Brian Kneafsey sold 25,000 shares of the business's stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $2.87, for a total value of $71,750.00. Following the transaction, the insider owned 696,598 shares in the company, valued at $1,999,236.26. This represents a 3.46% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 561,736 shares of company stock worth $1,739,383 over the last quarter. 35.52% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Blend Labs

Several institutional investors and hedge funds have recently added to or reduced their stakes in BLND. Revolve Wealth Partners LLC bought a new position in Blend Labs during the fourth quarter valued at about $132,000. Wells Fargo & Company MN increased its stake in Blend Labs by 49.7% during the fourth quarter. Wells Fargo & Company MN now owns 121,206 shares of the company's stock valued at $510,000 after acquiring an additional 40,266 shares during the period. Invesco Ltd. increased its stake in Blend Labs by 1,230.9% during the fourth quarter. Invesco Ltd. now owns 1,576,347 shares of the company's stock valued at $6,636,000 after acquiring an additional 1,457,901 shares during the period. Raymond James Financial Inc. bought a new position in Blend Labs during the fourth quarter valued at about $2,864,000. Finally, Barclays PLC increased its stake in Blend Labs by 12.3% during the fourth quarter. Barclays PLC now owns 458,014 shares of the company's stock valued at $1,927,000 after acquiring an additional 50,240 shares during the period. 52.56% of the stock is currently owned by institutional investors.

Blend Labs Stock Up 3.9%

Shares of NYSE:BLND traded up $0.14 on Friday, reaching $3.61. The company had a trading volume of 3,679,277 shares, compared to its average volume of 3,593,417. Blend Labs has a twelve month low of $2.63 and a twelve month high of $5.53. The stock has a 50-day moving average price of $3.37 and a 200 day moving average price of $3.43. The stock has a market capitalization of $936.07 million, a P/E ratio of -24.03 and a beta of 1.24.

Blend Labs (NYSE:BLND - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported ($0.03) earnings per share for the quarter, missing analysts' consensus estimates of $0.02 by ($0.05). The business had revenue of $31.52 million during the quarter, compared to the consensus estimate of $31.93 million. Blend Labs has set its Q3 2025 guidance at EPS. On average, sell-side analysts predict that Blend Labs will post -0.19 earnings per share for the current fiscal year.

Blend Labs Company Profile

Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.